MitchellCreininMD

Obstetrics & Gynecology • Sacramento, CA

General Gynecology

Professor and Director of Family Planning, Department of Obstetrics and Gynecology, UC Davis

Join to view full profile

Dr. Creinin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Creinin's full profile

Already have an account?

Office
4860 Y St
Suite 2500
Sacramento, CA 95817
Phone+1 916-734-6670
Is this information wrong?

Education & Training

University of California (San Francisco)Residency, Obstetrics and Gynecology, 1989 - 1992
University of California (San Francisco) School of MedicineInternship, Transitional Year, 1988 - 1989
Northwestern University The Feinberg School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 2011 - 2024
PA State Medical License 1994 - 2012
HI State Medical License 1990 - 1992
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Mifepristone and Misoprostol for Fetal Demise Start of enrollment: 2005 Jan 01
Completed
Phase 4
Mifepristone at Same Time Multicenter Study Start of enrollment: 2004 Jun 01
Completed
Phase 4
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra Start of enrollment: 2005 Jun 01
Completed
Phase 4
Understanding Women's Contraceptive Expectations at the Time of a First Trimester Surgical Abortion Start of enrollment: 2012 Dec 01
Completed
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive Start of enrollment: 2013 Dec 01
Terminated
Phase 4
Survey of Women's Choice of Delivery Before Consulting With Her Obstetrician Start of enrollment: 2013 Sep 01
Terminated
Comparative Effectiveness of Pregnancy Failure Management Regimens Start of enrollment: 2014 Jan 01
Completed
Phase 3
Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill Start of enrollment: 2018 Jul 24
Completed
Phase 2
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception Start of enrollment: 2020 Mar 03
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial.
Mitchell D Creinin, Hongsheng Wu, David Hubacher, Courtney A Schreiber, Bliss Kaneshiro, Kavita Nanda, Diana L Blithe, Jill E Brown> ;Contraception. 2024 Feb 29
Understanding the mechanical behavior of intrauterine devices during simulated removal.
Valeria La Saponara, Shuhao Wan, Bhagyashree Nagarkar, Faress Zwain, Mitchell D Creinin> ;Contraception. 2024 May 1
The benefits of estetrol addition to drospirenone for contraception.
Jean Michel Foidart, Kristina Gemzell-Danielsson, Ali Kubba, Jonathan Douxfils, Mitchell D Creinin, Ulysse Gaspard> ;AJOG Global Reports. 2023 Nov 1
Contraceptive efficacy should primarily be measured using life table pregnancy rates.
Christine K Mauck, Clint Dart, Andrea Thurman, Mitchell D Creinin> ;Contraception. 2023 Nov 1
1 citations
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
Mitchell D Creinin, Alicyoy Angulo, Enrico Colli, David F Archer> ;Contraception. 2023 Dec 1
Early pregnancy loss medical management in clinical practice.
Courtney C Baker, Brenda T Wu, Gloria Han, Anne N Flynn, Mitchell D Creinin> ;Contraception. 2023 Oct 1
Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871...
Mitchell D Creinin, Courtney A Schreiber, David K Turok, Carrie Cwiak, Beatrice A Chen, Andrea I Olariu> ;American Journal of Obstetrics and Gynecology. 2023 Sep 1
1 citations
Hormonal therapies and venous thrombosis: considerations for prevention and management-a reappraisal.
Jonathan Douxfils, Laure Morimont, Mitchell D Creinin, Ulysse Gaspard, Jean-Michel Foidart> ;Research and Practice in Thrombosis and Haemostasis. 2023 May 1
2 citations
Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
Mitchell D Creinin, Kurt T Barnhart, Lori M Gawron, David Eisenberg, R Garn Mabey Jr, Jeffrey T Jensen> ;Obstetrics and Gynecology. 2023 May 1
Management of cesarean scar ectopic pregnancies at an academic referral center: A case series.
Brenda T Wu, Zoe Feld, Mitchell D Creinin> ;Contraception. 2023 Jul 1
Extending use of levonorgestrel 52 mg intrauterine device to 8 years.
Mitchell D Creinin, Jeffrey T Jensen> ;American Journal of Obstetrics and Gynecology. 2023 Jul 1
1 citations
Complex Family Planning fellowship graduates' intended practice plans and barriers to practicing in areas of unmet need.
Tali Pomerantz, Matthew D Ponzini, Machelle D Wilson, Mitchell D Creinin> ;Contraception. 2023 Jul 1
7 citations
Medication abortion with misoprostol-only: A sample protocol.
Elizabeth G Raymond, Alice Mark, Daniel Grossman, Anitra Beasley, Kristyn Brandi, Jen Castle, Mitchell D Creinin, Caitlin Gerdts, Laura Gil, Melissa Grant, April Lockl...> ;Contraception. 2023 May 1
2 citations
Hormonal therapies and venous thrombosis: Estrogen matters!
Laure Morimont, Mitchell D Creinin, Ulysse Gaspard, Jean-Michel Foidart, Jonathan Douxfils> ;Research and Practice in Thrombosis and Haemostasis. 2023 Jan 1
2 citations
Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation.
Cassandra M Gilbert, Matthew D Ponzini, Machelle D Wilson, Mitchell D Creinin, Matulich, M.> ;Contraception. 2023 Apr 1
ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression.
Mitchell D Creinin> ;Obstetrics and Gynecology. 2022 Dec 1
Comparing IUC and Tubal Ligation.
Mitchell D Creinin, Melody Y Hou> ;Journal of General Internal Medicine. 2023 Jan 1
6 citations
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Melissa J Chen, Jeffrey T Jensen, Sharon L Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Celine Bouchard, David F Archer, Mau...> ;Contraception. 2022 Dec 1
5 citations
The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study.
Anna Glasier, Alison Edelman, Mitchell D Creinin, Vivian Brache, Carolyn L Westhoff, Leo Han, Melissa J Chen, Agnes Hemon> ;Contraception. 2023 Jan 1
2 citations
Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial.
David Hubacher, Courtney A Schreiber, David K Turok, Jeffrey T Jensen, Mitchell D Creinin, Kavita Nanda, Katharine O'Connell White, Ila Dayananda, Stephanie B Teal, Pa...> ;Eclinicalmedicine. 2022 Sep 1
5 citations
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy wo...
Sharon L Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Celine Bouchard, Melissa J Chen, Jeffrey T Jensen, Carolyn L Westhoff,...> ;Contraception. 2022 Dec 1
5 citations
Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception.
Leo Han, Mitchell D Creinin, Agnes Hemon, Anna Glasier, Melissa J Chen, Alison Edelman> ;Contraception. 2022 Aug 1
5 citations
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
Jeffrey T Jensen, Sharon L Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Céline Bouchard, Melissa J Chen, Dan Apter, Maud Jos...> ;Contraception. 2022 Dec 1
3 citations
Implementation of telemedicine preoperative visits for abortion procedures through 18 weeks gestation at a Northern California hospital-based center.
Melody Y Hou, Melissa J Chen, Mitchell D Creinin, Uhm, S., Matulich, M.> ;Contraception. 2022 Oct 1
6 citations
Recommendations for standardization of bleeding data analyses in contraceptive studies.
Mitchell D Creinin, Carolina Sales Vieira, Carolyn L Westhoff, Diana J A Mansour> ;Contraception. 2022 Aug 1
Join now to see all

Journal Articles

Gabapentin for Pain Management After Osmotic Dilator Insertion and Prior to D&E
Mitchell D Creinin, Natasha R Schimmoeller, Melissa C Matulich, Melody Y Hou, Juliana Melo, Contraception
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss
Sarita Sonalkar, Courtney A Schreiber, Mitchell D Creinin, Kurt T Barnhart, The New England Journal of Medicine

Lectures

Contraception Across the Transmasculine Spectrum
UC Davis Health System, Napa, California - 6/4/2012

Authored Content

Contraception Across the Transmasculine SpectrumJune 2020
Gabapentin for Pain Management After Osmotic Dilator Insertion and Prior to D&EJanuary 2020

Press Mentions

IUD Cuts Heavy Menses in Nulliparous Patients with ObesityMay 13th, 2022
A New Type of Copper IUD Designed to Decrease Menstrual Cramps and Make Insertion Smoother Is a Step Closer to FDA ApprovalJuly 1st, 2021
Mithra Pharmaceuticals S A : Nextstellis® Receives FDA Marketing Exclusivity and Phase III Data PublishedMay 31st, 2021
Join now to see all